|
|
||||||||
Ann Thorac Surg 2001;71:844-851
© 2001 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, Hôpital Bichat, Paris, France
b INSERM U523, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtriére, Paris, France
c Department of Cardiology, Hôpital Boucicaut, Paris, France
Address reprint requests to Dr Menasché, Service de Chirurgie Cardiovasculaire B, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
e-mail: ccv-bloc.sec3{at}bch.ap-hop-paris.fr
Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31Feb 2, 2000.
Background. This study assessed the extent to which the initial degree of functional impairment and the number of injected cells may influence the functional improvement provided by autologous skeletal myoblast transplantation into infarcted myocardium.
Methods. One week after left coronary artery ligation, 44 rats received into the infarcted scar, autologous skeletal myoblasts expanded in vitro for 7 days (mean, 3.5 x 106, n = 21), or culture medium alone (controls, n = 23). Left ventricular function was assessed by two-dimensional echocardiography.
Results. When transplanted hearts were stratified according to their baseline ejection fraction, a significant improvement occurred at 2 months in the less than 25% (from 21.4% to 37%), 25% to 35% (from 29% to 43.8%), and in the 35% to 40% (from 37.2% to 41.7%) groups, compared to controls (p = 0.048, 0.0057, and 0.034, respectively), but not in the more than 40% stratum. A significant linear relationship was found between the improvement in ejection fraction and the number of injected myoblasts, both at 1 and 2 months after transplantation (p < 0.0001).
Conclusions. Autologous myoblast transplantation is functionally effective over a wide range of postinfarct ejection fractions, including in the sickest hearts provided that they are injected with a sufficiently high number of cells.
This article has been cited by other articles:
![]() |
J. J. Gavira, E. Nasarre, G. Abizanda, M. Perez-Ilzarbe, A. de Martino-Rodriguez, J. A. Garcia de Jalon, M. Mazo, A. Macias, I. Garcia-Bolao, B. Pelacho, et al. Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction Eur. Heart J., August 22, 2009; (2009) ehp342v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lu, H. K. Haider, S. Jiang, and M. Ashraf Sca-1+ Stem Cell Survival and Engraftment in the Infarcted Heart: Dual Role for Preconditioning-Induced Connexin-43 Circulation, May 19, 2009; 119(19): 2587 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, M. A. Stagg, S. Fukushima, G. K. R. Soppa, U. Siedlecka, S. J. Youssef, K. Suzuki, M. H. Yacoub, and C. M. N. Terracciano Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H927 - H936. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hamamoto, J. H. Gorman III, L. P. Ryan, R. Hinmon, T. P. Martens, M. D. Schuster, T. Plappert, M. Kiupel, M. G. St. John-Sutton, S. Itescu, et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann. Thorac. Surg., March 1, 2009; 87(3): 794 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dib, J. Dinsmore, Z. Lababidi, B. White, S. Moravec, A. Campbell, A. Rosenbaum, K. Seyedmadani, W. A. Jaber, C. S. Rizenhour, et al. One-Year Follow-Up of Feasibility and Safety of the First U.S., Randomized, Controlled Study Using 3-Dimensional Guided Catheter-Based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy (CAuSMIC Study) J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 9 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, T. R. Payne, B. Zheng, H. Oshima, N. Momoi, K. Tobita, B. B. Keller, J. A. Phillippi, B. Peault, and J. Huard Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1869 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guo, H. Kh. Haider, C. Wang, R.-S. Tan, W. S.N. Shim, P. Wong, and E. K.W. Sim Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation Ann. Thorac. Surg., December 1, 2008; 86(6): 1841 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bonaros, R. Rauf, E. Werner, B. Schlechta, E. Rohde, A. Kocher, J. Bonatti, and G. Laufer Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 249 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-O. Kim, S. Verma, R. D. Weisel, S. Fazel, Z.-Q. Jia, T. Mizuno, and R.-K. Li Preservation of heart function in diabetic rats by the combined effects of muscle cell implantation and insulin therapy Eur J Heart Fail, January 1, 2008; 10(1): 14 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guo, H. Kh. Haider, W. S.N. Shim, R.-S. Tan, L. Ye, S. Jiang, P. K. Law, P. Wong, and E. K.W. Sim Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1332 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Niagara, H. Kh. Haider, S. Jiang, and M. Ashraf Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart Circ. Res., March 2, 2007; 100(4): 545 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, M. Perez-Ilzarbe, G. Abizanda, A. Garcia-Rodriguez, J. Orbe, J. A. Paramo, M. Belzunce, G. Rabago, J. Barba, J. Herreros, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction Cardiovasc Res, September 1, 2006; 71(4): 744 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, T. Yasuda, R. D. Weisel, and R.-K. Li Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H939 - H947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siepe, M.-N. Giraud, M. Pavlovic, C. Receputo, F. Beyersdorf, P. Menasche, T. Carrel, and H. T. Tevaearai Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 124 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murry, H. Reinecke, and L. M. Pabon Regeneration Gaps: Observations on Stem Cells and Cardiac Repair J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, J. Herreros, A. Perez, M. J. Garcia-Velloso, J. Barba, F. Martin-Herrero, C. Canizo, A. Martin-Arnau, J. M. Marti-Climent, M. Hernandez, et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 799 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murry, L. J. Field, and P. Menasche Cell-Based Cardiac Repair: Reflections at the 10-Year Point Circulation, November 15, 2005; 112(20): 3174 - 3183. [Full Text] [PDF] |
||||
![]() |
T. M. Yau, C. Kim, D. Ng, G. Li, Y. Zhang, R. D. Weisel, and R.-K. Li Increasing Transplanted Cell Survival With Cell-Based Angiogenic Gene Therapy Ann. Thorac. Surg., November 1, 2005; 80(5): 1779 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.L. Tang, S. Fazel, R. D. Weisel, S. Verma, and R.-K. Li Optimizing cardiac cell therapy: From processing to delivery J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 966 - 968. [Full Text] [PDF] |
||||
![]() |
P. I. McConnell, C. L. del Rio, D. B. Jacoby, M. Pavlicova, P. Kwiatkowski, A. Zawadzka, J. H. Dinsmore, L. Astra, S. Wisel, and R. E. Michler Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1001 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tambara, G. U. Premaratne, G. Sakaguchi, N. Kanemitsu, X. Lin, H. Nakajima, Y. Sakakibara, Y. Kimura, M. Yamamoto, Y. Tabata, et al. Administration of Control-Released Hepatocyte Growth Factor Enhances the Efficacy of Skeletal Myoblast Transplantation in Rat Infarcted Hearts by Greatly Increasing Both Quantity and Quality of the Graft Circulation, August 30, 2005; 112(9_suppl): I-129 - I-134. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Azarnoush, A. Maurel, L. Sebbah, C. Carrion, A. Bissery, C. Mandet, J. Pouly, P. Bruneval, A. A. Hagege, and P. Menasche Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1{alpha} J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 173 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yasuda, R. D. Weisel, C. Kiani, D. A.G. Mickle, M. Maganti, and R.-K. Li Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 904 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Davani, F. Deschaseaux, D. Chalmers, P. Tiberghien, and J.-P. Kantelip Can stem cells mend a broken heart? Cardiovasc Res, February 1, 2005; 65(2): 305 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-B. Liu, P. W. M. Fedak, R. D. Weisel, T. Yasuda, G. Kiani, D. A. G. Mickle, Z.-Q. Jia, and R.-K. Li Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2840 - H2849. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Smits, R.-J. M. van Geuns, D. Poldermans, M. Bountioukos, E. E. M. Onderwater, C. H. Lee, A. P. W. M. Maat, and P. W. Serruys Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with Six-Month Follow-Up J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2063 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujii, T. M. Yau, R. D. Weisel, N. Ohno, D. A. G. Mickle, N. Shiono, T. Ozawa, K. Matsubayashi, and R.-K. Li Cell transplantation to prevent heart failure: a comparison of cell types Ann. Thorac. Surg., December 1, 2003; 76(6): 2062 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herreros, F. Prosper, A. Perez, J. J Gavira, M. J. Garcia-Velloso, J. Barba, P. L Sanchez, C. Canizo, G. Rabago, J. M Marti-Climent, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction Eur. Heart J., November 2, 2003; 24(22): 2012 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tambara, Y. Sakakibara, G. Sakaguchi, F. Lu, G. U. Premaratne, X. Lin, K. Nishimura, and M. Komeda Transplanted Skeletal Myoblasts Can Fully Replace the Infarcted Myocardium When They Survive in the Host in Large Numbers Circulation, September 9, 2003; 108(90101): II-259 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Thompson, S. M. Emani, B. H. Davis, E. J. van den Bos, Y. Morimoto, D. Craig, D. Glower, and D. A. Taylor Comparison of Intracardiac Cell Transplantation: Autologous Skeletal Myoblasts Versus Bone Marrow Cells Circulation, September 9, 2003; 108(90101): II-264 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.L. Tang, P. W.M. Fedak, T. M. Yau, R. D. Weisel, A. Kulik, D. A.G. Mickle, and R.-K. Li Cell transplantation to improve ventricular function in the failing heart Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche Cell transplantation in myocardium Ann. Thorac. Surg., June 1, 2003; 75(90060): S20 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. W, H. K. Haider, and P. K. Law Single fiber skeletal muscle transplantation or purified myoblast engraftment? J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1181 - 1182. [Full Text] [PDF] |
||||
![]() |
J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field Myocyte and myogenic stem cell transplantation in the heart Cardiovasc Res, May 1, 2003; 58(2): 336 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche Skeletal muscle satellite cell transplantation Cardiovasc Res, May 1, 2003; 58(2): 351 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reffelmann and R. A. Kloner Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res, May 1, 2003; 58(2): 358 - 368. [Full Text] [PDF] |
||||
![]() |
O. Agbulut, M.-L. Menot, Z. Li, F. Marotte, D. Paulin, A. A. Hagege, C. Chomienne, J.-L. Samuel, and P. Menasche Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy Cardiovasc Res, May 1, 2003; 58(2): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche, A. A. Hagege, J.-T. Vilquin, M. Desnos, E. Abergel, B. Pouzet, A. Bel, S. Sarateanu, M. Scorsin, K. Schwartz, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1078 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Minami, H. Reinecke, and C. E. Murry Skeletal muscle meets cardiac muscle: Friends or foes? J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1084 - 1086. [Full Text] [PDF] |
||||
![]() |
N. Al Attar, C. Carrion, S. Ghostine, I. Garcin, J.-T. Vilquin, A. A. Hagege, and P. Menasche Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat Cardiovasc Res, April 1, 2003; 58(1): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Pagani, H. DerSimonian, A. Zawadzka, K. Wetzel, A. S. B. Edge, D. B. Jacoby, J. H. Dinsmore, S. Wright, T. H. Aretz, H. J. Eisen, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation J. Am. Coll. Cardiol., March 5, 2003; 41(5): 879 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text] |
||||
![]() |
P Menasche and M Desnos Cardiac reparation: fixing the heart with cells, new vessels and genes Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D73 - D81. [Abstract] [PDF] |
||||
![]() |
C.E. MURRY, M.L. WHITNEY, M.A. LAFLAMME, H. REINECKE, and L.J. FIELD Cellular Therapies for Myocardial Infarct Repair Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 519 - 526. [Abstract] [PDF] |
||||
![]() |
R. C. Gorman and J. H. Gorman III Cellular myoplasty: what are we really trying to achieve? Ann. Thorac. Surg., January 1, 2002; 73(1): 342 - 343. [Full Text] [PDF] |
||||
![]() |
B. Pouzet, S. Ghostine, J.-T. Vilquin, I. Garcin, M. Scorsin, A. A. Hagege, D. Duboc, K. Schwartz, and P. Menasche Is Skeletal Myoblast Transplantation Clinically Relevant in the Era of Angiotensin-Converting Enzyme Inhibitors? Circulation, September 18, 2001; 104 (2009): I-223 - I-228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |